Sector: Pharmaceuticals & Biotechnology

Small Cap

MPS Pharma Share Price

Q: What is the Market Capitalization of MPS Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for MPS Pharma Ltd. is approximately ₹ 3.1 Cr.

Q: What are the PE and PB ratios for MPS Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for MPS Pharma Ltd. is -3.3, and the Price-to-Book (PB) ratio is 4.7.

Q: What is the 52-Week High and Low for MPS Pharma Ltd.?

Over the past 52 weeks, the highest price reached by MPS Pharma Ltd. shares was ₹ 4.02, and the lowest price was ₹ 1.6.

Q: Who are the major shareholders of MPS Pharma Ltd.?

Significant shareholdings in MPS Pharma Ltd. typically include entities such as: Public Promoter Other Institutions (Note: Shareholding patterns can change; this represents major holders based on recent filings).

Q: Who are the peers of MPS Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, MPS Pharma Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

MPS Pharma Ltd.

₹1.76

0.08(4.76%)

Trade Now

No Graph

NSE :

Open Free Demat Account

MPS Pharma Performance

Price Movement

N/A

₹1.60

₹1.76

↘ Today's Low↗ Today's High

1 Year Performance

Data is not available

Markets Today

High₹1.76

Low₹1.60

Open at₹1.76

Prev Close₹1.68

Volumes1.15 K

Avg Price₹1.65

Lower Circuit₹1.60

Upper Circuit₹1.76

Historical Performance

3M High₹1.85

3M Low₹1.60

1 Yr High₹4.02

1 Yr Low₹1.60

3 Yr High₹4.33

3 Yr Low₹1.60

5 Yr High₹4.33

5 Yr Low₹0.42

MPS Pharma Fundamentals

Market Cap

Low in industry

3.10 Cr.

PE Ratio (TTM)

Negative PE TTM

-3.30

Dividend Yield

Net Profit TTM

9% decr over last year

-0.94

Net Profit Growth

9% decr over last year

-0.94

PEG Ratio

Above industry Median

0.40

ROE

97% decr over last year

-83.08

Operating Revenue TTM

Operating Revenue Growth

Book Value

Above industry Median

4.70

MFI

MFI strongly Oversold

17.03

RSI

RSI oversold

23.07

EPS (TTM)

Debt to Equity

Face Value

Operating Profit Margin Qtr.

Operating Profit Qtr.

Net Profit Qtr.

Operating Revenue Qtr.

PB Ratio

4.70

MPS Pharma Financials

Data not available for chart

Indicator	Dec 2025	Sep 2025	Jun 2025	Mar 2025	Dec 2024
Total Revenue	0	0	0	0	0
Operating Expense	0.19	0.19	0.19	0.19	0.18
Operating Profit	-0.19	-0.19	-0.19	-0.19	-0.18
Depreciation	0.04	0.04	0.04	0.04	0.04
Interest	0	0	0	0	0
Tax	-0.01	-0.01	-0.01	0.05	0
Net Profit	-0.22	-0.22	-0.22	-0.28	-0.17

MPS Pharma Technicals

MPS Pharma Ltd. EMA & SMA

₹1.76

0.08 (4.76%)

↗ Bullish Moving Average

↘ Bearish Moving Average

Day EMA5 ₹1.7

Day EMA10 ₹1.8

Day EMA12 ₹1.8

Day EMA20 ₹1.9

Day EMA26 ₹2

Day EMA50 ₹2.4

Day EMA100 ₹2.6

Day EMA200 ₹2.5

MPS Pharma Support and Resistance

Resistance

First Resistance₹1.74

Second Resistance₹1.83

Third Resistance₹1.90

Support

First Support₹1.58

Second Support₹1.51

Third Support₹1.42

Technical Indicators

Day RSI23.07

Day MFI17.03

Day ADX51.73

Day Commodity Channel Index-116.10

William-89.36

Day MACD-0.23

Day MACD Signal Line-0.25

Day ATR0.09

Day ROC125-28.57

Day ROC21-22.90

MPS Pharma Shareholding Pattern

Held By	Sep 2024	Dec 2024	Mar 2025	Jun 2025	Sep 2025	Dec 2025
Promoter	35.9	35.9	35.9	35.9	35.9	35.9
FII	0	0	0	0	0	0
DII	0.6	0.6	0.6	0.6	0.6	0.6
Public	63.5	63.5	63.5	63.5	63.5	63.5

MPS Pharma Delivery And Volume

Period	Combined Delivery Volume	NSE+BSE Traded Volume Avg	Daily Avg Delivery Volume %
Day	1	1	100.00%
Week	0	0	undefined%
1 Month	0	0	undefined%
6 Month	346	346	100.00%

MPS Pharma SWOT Analysis

Strengths3

Weakness14

Opportunity0

Threats0

PEG lower than Industry PEG

Strong cash generating ability from core business - Improving Cash Flow from operation for last 2 years

Stock with Low PE (PE < = 10)

MPS Pharma Corporate Action

Ex-Date	Dividend Amount	Dividend Type	Record Date	Instrument Type
No Record Found

MPS Pharma Stock Comparison

Financials	Accretion Nutraveda Ltd.	Rekvina Laboratories Ltd.	Vivimed Labs Ltd.	Aptus Pharma Ltd.	Amanta Healthcare Ltd.	Anlon Healthcare Ltd.
Price (₹)	₹193	₹25.08	₹8.43	₹256.35	₹104	₹115.35
% Change	0.21%	1.99%	4.98%	1.99%	-1.38%	-3.98%
Revenue TTM (₹ Cr)	-	₹0.54	₹104.12	-	₹282.74	-
Net Profit TTM (₹ Cr)	-	₹-0.24	₹-24.37	-	₹15.30	-
PE TTM	50.70	-63.80	-2.90	56.70	26.50	-
1 Year Return		457.33	743		-17.19	27.77
ROCE	-	-	-5.63	-	-	-

Similar Stocks

PATELCHEM

Patel Chem Specialities Ltd.

₹ 71.70

-0.42%

APL

Asston Pharmaceuticals Ltd.

₹ 81.00

-1.22%

AMRUTANJAN

Amrutanjan Health Care Ltd.

₹ 604.00

-1.99%

ASTONEALAB

Astonea Labs Ltd.

₹ 160.00

+2.50%

AMWILL

Amwill Health Care Ltd.

₹ 36.00

+2.27%

SENORES

Senores Pharmaceuticals Ltd.

₹ 791.10

-2.37%

INNOVACAP

Innova Captab Ltd.

₹ 690.00

+3.06%

VALIANTLAB

Valiant Laboratories Ltd.

₹ 59.10

+1.37%

SHELTER

Shelter Pharma Ltd.

₹ 37.33

-6.23%

TLL

Trident Lifeline Ltd.

₹ 254.00

-3.37%

DPL

Dipna Pharmachem Ltd.

₹ 10.00

+5.26%

ACHYUT

Achyut Healthcare Ltd.

₹ 5.47

+0.74%

SIGACHI

Sigachi Industries Ltd.

₹ 21.22

-3.68%

WINDLAS

Windlas Biotech Ltd.

₹ 774.00

-0.82%

VINEETLAB

Vineet Laboratories Ltd.

₹ 31.51

-1.62%

CBPL

Chandra Bhagat Pharma Ltd.

₹ 40.10

+0.00%

SOLARA

Solara Active Pharma Sciences Ltd.

₹ 472.60

+0.23%

RAJNISH

Rajnish Wellness Ltd.

₹ 0.46

+0.00%

ZIMLAB

Zim Laboratories Ltd.

₹ 72.00

+1.72%

BPLPHARMA

Bharat Parenterals Ltd.

₹ 1151.90

+4.67%

MEDICO

Medico Remedies Ltd.

₹ 48.00

+4.53%

SGRL

Shree Ganesh Remedies Ltd.

₹ 506.00

+0.54%

DCAL

Dishman Carbogen Amcis Ltd.

₹ 182.40

+0.07%

FAQ's on ADVIKLA

What is the Market Capitalization of MPS Pharma Ltd.?

Market capitalization (market cap) represents the total market value of a company's outstanding shares based on its current share price. As of 2 June 2025, the market cap for MPS Pharma Ltd. is approximately ₹ 3.1 Cr.

What are the PE and PB ratios for MPS Pharma Ltd.?

Based on recent data, the Price-to-Earnings (PE) ratio for MPS Pharma Ltd. is -3.3, and the Price-to-Book (PB) ratio is 4.7.

What is the 52-Week High and Low for MPS Pharma Ltd.?

Over the past 52 weeks, the highest price reached by MPS Pharma Ltd. shares was ₹ 4.02, and the lowest price was ₹ 1.6.

Who are the major shareholders of MPS Pharma Ltd.?

Significant shareholdings in MPS Pharma Ltd. typically include entities such as:

Public
Promoter
Other Institutions

(Note: Shareholding patterns can change; this represents major holders based on recent filings).

Who are the peers of MPS Pharma Ltd. in the Pharmaceuticals & Biotechnology sector?

In the Pharmaceuticals & Biotechnology sector, MPS Pharma Ltd. is often compared with other major players such as Accretion Nutraveda, Rekvina Laboratories, Vivimed Labs, Corona Remedies, Sudeep Pharma and Curis Lifesciences for analysis and benchmarking.

Invest Anytime, Anywhere

By signing up I certify terms, conditions & privacy policy